Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Biologic Products in Nerve Repair Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Biologic Products in Nerve Repair Market Outlook, In‑Depth Analysis & Forecast to 2031
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Biologic Products in Nerve Repair Market Size(US$)
CAGR 2025-2031
21.0%
Market Size,2031
USD 489
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 156 million
Market Forecast in 2031(Value)
US$ 489 million
CAGR
21.0%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Biologic Products in Nerve Repair market is projected to grow from US$ 131 million in 2024 to US$ 489 million by 2031, at a CAGR of 21.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Nerves can be damaged in a number of ways. When a nerve is cut due to a traumatic injury or surgery, functionality of the nerve may be compromised, causing the nerve to no longer carry the signals to and from the brain to the muscles and skin and reducing or eliminating functionality. Nerve damage or discontinuity of this type generally requires a surgical repair.
From a downstream perspective, Direct Nerve Repair accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Biologic Products in Nerve Repair leading manufacturers including Axogen, Integra, Synovis, Collagen Matrix, Polyganics, Checkpoint Surgical, Neurotex, Toyobo, etc., dominate supply; the top five capture approximately % of global revenue, with Axogen leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Biologic Products in Nerve Repair market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
- Axogen
- Integra
- Synovis
- Collagen Matrix
- Polyganics
- Checkpoint Surgical
- Neurotex
- Toyobo
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Nerve Conduit
- Nerve Wrap
- Nerve Graft
- Others
Segment by Application
- Direct Nerve Repair
- Nerve Grafting
Chapter Outline
Chapter 1: Defines the Biologic Products in Nerve Repair study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Study Coverage
1.1 Introduction to Biologic Products in Nerve Repair: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Biologic Products in Nerve Repair Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Nerve Conduit
1.2.3 Nerve Wrap
1.2.4 Nerve Graft
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Biologic Products in Nerve Repair Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Direct Nerve Repair
1.3.3 Nerve Grafting
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biologic Products in Nerve Repair Revenue Estimates and Forecasts 2020-2031
2.2 Global Biologic Products in Nerve Repair Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Biologic Products in Nerve Repair Sales Estimates and Forecasts 2020-2031
2.4 Global Biologic Products in Nerve Repair Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Biologic Products in Nerve Repair Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Biologic Products in Nerve Repair Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Nerve Conduit Market Size by Manufacturers
3.5.2 Nerve Wrap Market Size by Manufacturers
3.5.3 Nerve Graft Market Size by Manufacturers
3.5.4 Others Market Size by Manufacturers
3.6 Global Biologic Products in Nerve Repair Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Biologic Products in Nerve Repair Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Biologic Products in Nerve Repair Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Biologic Products in Nerve Repair Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Biologic Products in Nerve Repair Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Biologic Products in Nerve Repair Sales and Revenue by Type (2020-2031)
6.4 North America Biologic Products in Nerve Repair Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Biologic Products in Nerve Repair Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Biologic Products in Nerve Repair Sales and Revenue by Type (2020-2031)
7.4 Europe Biologic Products in Nerve Repair Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Biologic Products in Nerve Repair Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Biologic Products in Nerve Repair Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Biologic Products in Nerve Repair Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Biologic Products in Nerve Repair Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Biologic Products in Nerve Repair Sales and Revenue by Type (2020-2031)
9.4 Central and South America Biologic Products in Nerve Repair Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Biologic Products in Nerve Repair Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Biologic Products in Nerve Repair Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Biologic Products in Nerve Repair Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Biologic Products in Nerve Repair Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Axogen
11.1.1 Axogen Corporation Information
11.1.2 Axogen Business Overview
11.1.3 Axogen Biologic Products in Nerve Repair Product Models, Descriptions and Specifications
11.1.4 Axogen Biologic Products in Nerve Repair Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Axogen Biologic Products in Nerve Repair Sales by Product in 2024
11.1.6 Axogen Biologic Products in Nerve Repair Sales by Application in 2024
11.1.7 Axogen Biologic Products in Nerve Repair Sales by Geographic Area in 2024
11.1.8 Axogen Biologic Products in Nerve Repair SWOT Analysis
11.1.9 Axogen Recent Developments
11.2 Integra
11.2.1 Integra Corporation Information
11.2.2 Integra Business Overview
11.2.3 Integra Biologic Products in Nerve Repair Product Models, Descriptions and Specifications
11.2.4 Integra Biologic Products in Nerve Repair Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Integra Biologic Products in Nerve Repair Sales by Product in 2024
11.2.6 Integra Biologic Products in Nerve Repair Sales by Application in 2024
11.2.7 Integra Biologic Products in Nerve Repair Sales by Geographic Area in 2024
11.2.8 Integra Biologic Products in Nerve Repair SWOT Analysis
11.2.9 Integra Recent Developments
11.3 Synovis
11.3.1 Synovis Corporation Information
11.3.2 Synovis Business Overview
11.3.3 Synovis Biologic Products in Nerve Repair Product Models, Descriptions and Specifications
11.3.4 Synovis Biologic Products in Nerve Repair Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Synovis Biologic Products in Nerve Repair Sales by Product in 2024
11.3.6 Synovis Biologic Products in Nerve Repair Sales by Application in 2024
11.3.7 Synovis Biologic Products in Nerve Repair Sales by Geographic Area in 2024
11.3.8 Synovis Biologic Products in Nerve Repair SWOT Analysis
11.3.9 Synovis Recent Developments
11.4 Collagen Matrix
11.4.1 Collagen Matrix Corporation Information
11.4.2 Collagen Matrix Business Overview
11.4.3 Collagen Matrix Biologic Products in Nerve Repair Product Models, Descriptions and Specifications
11.4.4 Collagen Matrix Biologic Products in Nerve Repair Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Collagen Matrix Biologic Products in Nerve Repair Sales by Product in 2024
11.4.6 Collagen Matrix Biologic Products in Nerve Repair Sales by Application in 2024
11.4.7 Collagen Matrix Biologic Products in Nerve Repair Sales by Geographic Area in 2024
11.4.8 Collagen Matrix Biologic Products in Nerve Repair SWOT Analysis
11.4.9 Collagen Matrix Recent Developments
11.5 Polyganics
11.5.1 Polyganics Corporation Information
11.5.2 Polyganics Business Overview
11.5.3 Polyganics Biologic Products in Nerve Repair Product Models, Descriptions and Specifications
11.5.4 Polyganics Biologic Products in Nerve Repair Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Polyganics Biologic Products in Nerve Repair Sales by Product in 2024
11.5.6 Polyganics Biologic Products in Nerve Repair Sales by Application in 2024
11.5.7 Polyganics Biologic Products in Nerve Repair Sales by Geographic Area in 2024
11.5.8 Polyganics Biologic Products in Nerve Repair SWOT Analysis
11.5.9 Polyganics Recent Developments
11.6 Checkpoint Surgical
11.6.1 Checkpoint Surgical Corporation Information
11.6.2 Checkpoint Surgical Business Overview
11.6.3 Checkpoint Surgical Biologic Products in Nerve Repair Product Models, Descriptions and Specifications
11.6.4 Checkpoint Surgical Biologic Products in Nerve Repair Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Checkpoint Surgical Recent Developments
11.7 Neurotex
11.7.1 Neurotex Corporation Information
11.7.2 Neurotex Business Overview
11.7.3 Neurotex Biologic Products in Nerve Repair Product Models, Descriptions and Specifications
11.7.4 Neurotex Biologic Products in Nerve Repair Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Neurotex Recent Developments
11.8 Toyobo
11.8.1 Toyobo Corporation Information
11.8.2 Toyobo Business Overview
11.8.3 Toyobo Biologic Products in Nerve Repair Product Models, Descriptions and Specifications
11.8.4 Toyobo Biologic Products in Nerve Repair Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Toyobo Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Biologic Products in Nerve Repair Industry Chain
12.2 Biologic Products in Nerve Repair Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Biologic Products in Nerve Repair Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Biologic Products in Nerve Repair Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Biologic Products in Nerve Repair Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Biologic Products in Nerve Repair Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
Table of Figures
List of Tables
Table 1. Global Biologic Products in Nerve Repair Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Biologic Products in Nerve Repair Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Biologic Products in Nerve Repair Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Biologic Products in Nerve Repair Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Biologic Products in Nerve Repair Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Biologic Products in Nerve Repair Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Biologic Products in Nerve Repair Sales by Region (2020-2025) & (K Units)
Table 8. Global Biologic Products in Nerve Repair Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Biologic Products in Nerve Repair Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Biologic Products in Nerve Repair Sales Share by Manufacturers (2020-2025)
Table 12. Global Biologic Products in Nerve Repair Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Biologic Products in Nerve Repair Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Biologic Products in Nerve Repair by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Products in Nerve Repair as of 2024)
Table 16. Global Biologic Products in Nerve Repair Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Biologic Products in Nerve Repair Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/Unit)
Table 18. Key Manufacturers Biologic Products in Nerve Repair Manufacturing Base and Headquarters
Table 19. Global Biologic Products in Nerve Repair Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Biologic Products in Nerve Repair Sales by Type (2020-2025) & (K Units)
Table 23. Global Biologic Products in Nerve Repair Sales by Type (2026-2031) & (K Units)
Table 24. Global Biologic Products in Nerve Repair Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Biologic Products in Nerve Repair Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Biologic Products in Nerve Repair ASP by Type (2020-2031) & (USD/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Biologic Products in Nerve Repair Sales by Application (2020-2025) & (K Units)
Table 29. Global Biologic Products in Nerve Repair Sales by Application (2026-2031) & (K Units)
Table 30. Biologic Products in Nerve Repair High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Biologic Products in Nerve Repair Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Biologic Products in Nerve Repair Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Biologic Products in Nerve Repair ASP by Application (2020-2031) & (USD/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Biologic Products in Nerve Repair Growth Accelerators and Market Barriers
Table 37. North America Biologic Products in Nerve Repair Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Biologic Products in Nerve Repair Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Biologic Products in Nerve Repair Growth Accelerators and Market Barriers
Table 40. Europe Biologic Products in Nerve Repair Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Biologic Products in Nerve Repair Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Biologic Products in Nerve Repair Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Biologic Products in Nerve Repair Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Biologic Products in Nerve Repair Growth Accelerators and Market Barriers
Table 45. Southeast Asia Biologic Products in Nerve Repair Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Biologic Products in Nerve Repair Investment Opportunities and Key Challenges
Table 47. Central and South America Biologic Products in Nerve Repair Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Biologic Products in Nerve Repair Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Biologic Products in Nerve Repair Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Axogen Corporation Information
Table 51. Axogen Description and Major Businesses
Table 52. Axogen Product Models, Descriptions and Specifications
Table 53. Axogen Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 54. Axogen Sales Value Proportion by Product in 2024
Table 55. Axogen Sales Value Proportion by Application in 2024
Table 56. Axogen Sales Value Proportion by Geographic Area in 2024
Table 57. Axogen Biologic Products in Nerve Repair SWOT Analysis
Table 58. Axogen Recent Developments
Table 59. Integra Corporation Information
Table 60. Integra Description and Major Businesses
Table 61. Integra Product Models, Descriptions and Specifications
Table 62. Integra Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Integra Sales Value Proportion by Product in 2024
Table 64. Integra Sales Value Proportion by Application in 2024
Table 65. Integra Sales Value Proportion by Geographic Area in 2024
Table 66. Integra Biologic Products in Nerve Repair SWOT Analysis
Table 67. Integra Recent Developments
Table 68. Synovis Corporation Information
Table 69. Synovis Description and Major Businesses
Table 70. Synovis Product Models, Descriptions and Specifications
Table 71. Synovis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Synovis Sales Value Proportion by Product in 2024
Table 73. Synovis Sales Value Proportion by Application in 2024
Table 74. Synovis Sales Value Proportion by Geographic Area in 2024
Table 75. Synovis Biologic Products in Nerve Repair SWOT Analysis
Table 76. Synovis Recent Developments
Table 77. Collagen Matrix Corporation Information
Table 78. Collagen Matrix Description and Major Businesses
Table 79. Collagen Matrix Product Models, Descriptions and Specifications
Table 80. Collagen Matrix Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Collagen Matrix Sales Value Proportion by Product in 2024
Table 82. Collagen Matrix Sales Value Proportion by Application in 2024
Table 83. Collagen Matrix Sales Value Proportion by Geographic Area in 2024
Table 84. Collagen Matrix Biologic Products in Nerve Repair SWOT Analysis
Table 85. Collagen Matrix Recent Developments
Table 86. Polyganics Corporation Information
Table 87. Polyganics Description and Major Businesses
Table 88. Polyganics Product Models, Descriptions and Specifications
Table 89. Polyganics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Polyganics Sales Value Proportion by Product in 2024
Table 91. Polyganics Sales Value Proportion by Application in 2024
Table 92. Polyganics Sales Value Proportion by Geographic Area in 2024
Table 93. Polyganics Biologic Products in Nerve Repair SWOT Analysis
Table 94. Polyganics Recent Developments
Table 95. Checkpoint Surgical Corporation Information
Table 96. Checkpoint Surgical Description and Major Businesses
Table 97. Checkpoint Surgical Product Models, Descriptions and Specifications
Table 98. Checkpoint Surgical Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 99. Checkpoint Surgical Recent Developments
Table 100. Neurotex Corporation Information
Table 101. Neurotex Description and Major Businesses
Table 102. Neurotex Product Models, Descriptions and Specifications
Table 103. Neurotex Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Neurotex Recent Developments
Table 105. Toyobo Corporation Information
Table 106. Toyobo Description and Major Businesses
Table 107. Toyobo Product Models, Descriptions and Specifications
Table 108. Toyobo Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 109. Toyobo Recent Developments
Table 110. Key Raw Materials Distribution
Table 111. Raw Materials Key Suppliers
Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 113. Milestones in Production Technology Evolution
Table 114. Distributors List
Table 115. Market Trends and Market Evolution
Table 116. Market Drivers and Opportunities
Table 117. Market Challenges, Risks, and Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologic Products in Nerve Repair Product Picture
Figure 2. Global Biologic Products in Nerve Repair Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Nerve Conduit Product Picture
Figure 4. Nerve Wrap Product Picture
Figure 5. Nerve Graft Product Picture
Figure 6. Others Product Picture
Figure 7. Global Biologic Products in Nerve Repair Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Direct Nerve Repair
Figure 9. Nerve Grafting
Figure 10. Biologic Products in Nerve Repair Report Years Considered
Figure 11. Global Biologic Products in Nerve Repair Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Biologic Products in Nerve Repair Revenue (2020-2031) & (US$ Million)
Figure 13. Global Biologic Products in Nerve Repair Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Biologic Products in Nerve Repair Revenue Market Share by Region (2020-2031)
Figure 15. Global Biologic Products in Nerve Repair Sales (2020-2031) & (K Units)
Figure 16. Global Biologic Products in Nerve Repair Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Biologic Products in Nerve Repair Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Biologic Products in Nerve Repair Sales Volume Market Share in 2024
Figure 19. Global Biologic Products in Nerve Repair Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Nerve Conduit Revenue Market Share by Manufacturer in 2024
Figure 22. Nerve Wrap Revenue Market Share by Manufacturer in 2024
Figure 23. Nerve Graft Revenue Market Share by Manufacturer in 2024
Figure 24. Others Revenue Market Share by Manufacturer in 2024
Figure 25. Global Biologic Products in Nerve Repair Sales Market Share by Type (2020-2031)
Figure 26. Global Biologic Products in Nerve Repair Revenue Market Share by Type (2020-2031)
Figure 27. Global Biologic Products in Nerve Repair Sales Market Share by Application (2020-2031)
Figure 28. Global Biologic Products in Nerve Repair Revenue Market Share by Application (2020-2031)
Figure 29. North America Biologic Products in Nerve Repair Sales YoY (2020-2031) & (K Units)
Figure 30. North America Biologic Products in Nerve Repair Revenue YoY (2020-2031) & (US$ Million)
Figure 31. North America Top 5 Manufacturers Biologic Products in Nerve Repair Sales Revenue (US$ Million) in 2024
Figure 32. North America Biologic Products in Nerve Repair Sales Volume (K Units) by Type (2020- 2031)
Figure 33. North America Biologic Products in Nerve Repair Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 34. North America Biologic Products in Nerve Repair Sales Volume (K Units) by Application (2020-2031)
Figure 35. North America Biologic Products in Nerve Repair Sales Revenue (US$ Million) by Application (2020-2031)
Figure 36. US Biologic Products in Nerve Repair Revenue (2020-2031) & (US$ Million)
Figure 37. Canada Biologic Products in Nerve Repair Revenue (2020-2031) & (US$ Million)
Figure 38. Mexico Biologic Products in Nerve Repair Revenue (2020-2031) & (US$ Million)
Figure 39. Europe Biologic Products in Nerve Repair Sales YoY (2020-2031) & (K Units)
Figure 40. Europe Biologic Products in Nerve Repair Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Europe Top 5 Manufacturers Biologic Products in Nerve Repair Sales Revenue (US$ Million) in 2024
Figure 42. Europe Biologic Products in Nerve Repair Sales Volume (K Units) by Type (2020-2031)
Figure 43. Europe Biologic Products in Nerve Repair Sales Revenue (US$ Million) by Type (2020-2031)
Figure 44. Europe Biologic Products in Nerve Repair Sales Volume (K Units) by Application (2020-2031)
Figure 45. Europe Biologic Products in Nerve Repair Sales Revenue (US$ Million) by Application (2020-2031)
Figure 46. Germany Biologic Products in Nerve Repair Revenue (2020-2031) & (US$ Million)
Figure 47. France Biologic Products in Nerve Repair Revenue (2020-2031) & (US$ Million)
Figure 48. U.K. Biologic Products in Nerve Repair Revenue (2020-2031) & (US$ Million)
Figure 49. Italy Biologic Products in Nerve Repair Revenue (2020-2031) & (US$ Million)
Figure 50. Russia Biologic Products in Nerve Repair Revenue (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Biologic Products in Nerve Repair Sales YoY (2020-2031) & (K Units)
Figure 52. Asia-Pacific Biologic Products in Nerve Repair Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Top 8 Manufacturers Biologic Products in Nerve Repair Sales Revenue (US$ Million) in 2024
Figure 54. Asia-Pacific Biologic Products in Nerve Repair Sales Volume (K Units) by Type (2020- 2031)
Figure 55. Asia-Pacific Biologic Products in Nerve Repair Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 56. Asia-Pacific Biologic Products in Nerve Repair Sales Volume (K Units) by Application (2020-2031)
Figure 57. Asia-Pacific Biologic Products in Nerve Repair Sales Revenue (US$ Million) by Application (2020-2031)
Figure 58. Indonesia Biologic Products in Nerve Repair Revenue (2020-2031) & (US$ Million)
Figure 59. Japan Biologic Products in Nerve Repair Revenue (2020-2031) & (US$ Million)
Figure 60. South Korea Biologic Products in Nerve Repair Revenue (2020-2031) & (US$ Million)
Figure 61. China Taiwan Biologic Products in Nerve Repair Revenue (2020-2031) & (US$ Million)
Figure 62. India Biologic Products in Nerve Repair Revenue (2020-2031) & (US$ Million)
Figure 63. Central and South America Biologic Products in Nerve Repair Sales YoY (2020-2031) & (K Units)
Figure 64. Central and South America Biologic Products in Nerve Repair Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Central and South America Top 5 Manufacturers Biologic Products in Nerve Repair Sales Revenue (US$ Million) in 2024
Figure 66. Central and South America Biologic Products in Nerve Repair Sales Volume (K Units) by Type (2021-2031)
Figure 67. Central and South America Biologic Products in Nerve Repair Sales Revenue (US$ Million) by Type (2020-2031)
Figure 68. Central and South America Biologic Products in Nerve Repair Sales Volume (K Units) by Application (2020-2031)
Figure 69. Central and South America Biologic Products in Nerve Repair Sales Revenue (US$ Million) by Application (2020-2031)
Figure 70. Brazil Biologic Products in Nerve Repair Revenue (2020-2025) & (US$ Million)
Figure 71. Argentina Biologic Products in Nerve Repair Revenue (2020-2025) & (US$ Million)
Figure 72. Middle East, and Africa Biologic Products in Nerve Repair Sales YoY (2020-2031) & (K Units)
Figure 73. Middle East and Africa Biologic Products in Nerve Repair Revenue YoY (2020-2031) & (US$ Million)
Figure 74. Middle East and Africa Top 5 Manufacturers Biologic Products in Nerve Repair Sales Revenue (US$ Million) in 2024
Figure 75. Middle East and Africa Biologic Products in Nerve Repair Sales Volume (K Units) by Type (2021-2031)
Figure 76. South America Biologic Products in Nerve Repair Sales Revenue (US$ Million) by Type (2020-2031)
Figure 77. Middle East and Africa Biologic Products in Nerve Repair Sales Volume (K Units) by Application (2020-2031)
Figure 78. Middle East and Africa Biologic Products in Nerve Repair Sales Revenue (US$ Million) by Application (2020-2031)
Figure 79. GCC Countries Biologic Products in Nerve Repair Revenue (2020-2025) & (US$ Million)
Figure 80. Turkey Biologic Products in Nerve Repair Revenue (2020-2025) & (US$ Million)
Figure 81. Egypt Biologic Products in Nerve Repair Revenue (2020-2025) & (US$ Million)
Figure 82. South Africa Biologic Products in Nerve Repair Revenue (2020-2025) & (US$ Million)
Figure 83. Biologic Products in Nerve Repair Industry Chain Mapping
Figure 84. Regional Biologic Products in Nerve Repair Manufacturing Base Distribution (%)
Figure 85. Global Biologic Products in Nerve Repair Production Market Share by Region (2020-2031)
Figure 86. Biologic Products in Nerve Repair Production Process
Figure 87. Regional Biologic Products in Nerve Repair Production Cost Structure
Figure 88. Channels of Distribution (Direct Vs Distribution)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
Related Reports
Biologic Products in Nerve Repair - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nerves can be damaged in a number of ways. When a nerve is cut due to a traumatic injury or surgery, functionality of the nerve may be compromised, causing the nerve to no longer carry the signals to and from the brain to the muscles and skin and reducing or eliminating functionality. Nerve damage or discontinuity of this type generally requires a surgical repair.
Published Date: 2024-01-24
Pages: 92
USD 3950.00
(Single User License)
Global Biologic Products in Nerve Repair Market Research Report 2024
Nerves can be damaged in a number of ways. When a nerve is cut due to a traumatic injury or surgery, functionality of the nerve may be compromised, causing the nerve to no longer carry the signals to and from the brain to the muscles and skin and reducing or eliminating functionality. Nerve damage or discontinuity of this type generally requires a surgical repair.
Published Date: 2024-01-31
Pages: 80
USD 2900.00
(Single User License)
Global Biologic Products in Nerve Repair Market Insights, Forecast to 2030
Nerves can be damaged in a number of ways. When a nerve is cut due to a traumatic injury or surgery, functionality of the nerve may be compromised, causing the nerve to no longer carry the signals to and from the brain to the muscles and skin and reducing or eliminating functionality. Nerve damage or discontinuity of this type generally requires a surgical repair.
Published Date: 2024-04-26
Pages: 87
USD 4900.00
(Single User License)
Global Biologic Products in Nerve Repair Market Research Report 2025
The global market for Biologic Products in Nerve Repair was valued at US$ 131 million in the year 2024 and is projected to reach a revised size of US$ 489 million by 2031, growing at a CAGR of 21.0% during the forecast period.
Published Date: 2025-02-25
Pages: 84
USD 2900.00
(Single User License)
Biologic Products in Nerve Repair- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biologic Products in Nerve Repair was estimated to be worth US$ 131 million in 2024 and is forecast to a readjusted size of US$ 489 million by 2031 with a CAGR of 21.0% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 92
USD 3950.00
(Single User License)
Global Biologic Products in Nerve Repair Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Biologic Products in Nerve Repair market size was US$ 131 million in 2024 and is forecast to a readjusted size of US$ 489 million by 2031 with a CAGR of 21.0% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 77
USD 4250.00
(Single User License)
Global Biologic Products in Nerve Repair Market Research Report 2026
The global Biologic Products in Nerve Repair market was valued at US$ 156 million in 2025 and is anticipated to reach US$ 581 million by 2032, at a CAGR of 21.0% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 114
USD 2900.00
(Single User License)
Biologic Products in Nerve Repair- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biologic Products in Nerve Repair was estimated to be worth US$ 156 million in 2025 and is projected to reach US$ 581 million, growing at a CAGR of 21.0% from 2026 to 2032.
Published Date: 2026-07-15
Pages: 129
USD 3950.00
(Single User License)
Biologic Products in Nerve Repair - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nerves can be damaged in a number of ways. When a nerve is cut due to a traumatic injury or surgery, functionality of the nerve may be compromised, causing the nerve to no longer carry the signals to and from the brain to the muscles and skin and reducing or eliminating functionality. Nerve damage or discontinuity of this type generally requires a surgical repair.
Published: 2024-01-24
Pages: 92
USD 3950.00 (Single User License)Global Biologic Products in Nerve Repair Market Research Report 2024
Nerves can be damaged in a number of ways. When a nerve is cut due to a traumatic injury or surgery, functionality of the nerve may be compromised, causing the nerve to no longer carry the signals to and from the brain to the muscles and skin and reducing or eliminating functionality. Nerve damage or discontinuity of this type generally requires a surgical repair.
Published: 2024-01-31
Pages: 80
USD 2900.00 (Single User License)Global Biologic Products in Nerve Repair Market Insights, Forecast to 2030
Nerves can be damaged in a number of ways. When a nerve is cut due to a traumatic injury or surgery, functionality of the nerve may be compromised, causing the nerve to no longer carry the signals to and from the brain to the muscles and skin and reducing or eliminating functionality. Nerve damage or discontinuity of this type generally requires a surgical repair.
Published: 2024-04-26
Pages: 87
USD 4900.00 (Single User License)Global Biologic Products in Nerve Repair Market Research Report 2025
The global market for Biologic Products in Nerve Repair was valued at US$ 131 million in the year 2024 and is projected to reach a revised size of US$ 489 million by 2031, growing at a CAGR of 21.0% during the forecast period.
Published: 2025-02-25
Pages: 84
USD 2900.00 (Single User License)Biologic Products in Nerve Repair- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biologic Products in Nerve Repair was estimated to be worth US$ 131 million in 2024 and is forecast to a readjusted size of US$ 489 million by 2031 with a CAGR of 21.0% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 92
USD 3950.00 (Single User License)Global Biologic Products in Nerve Repair Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Biologic Products in Nerve Repair market size was US$ 131 million in 2024 and is forecast to a readjusted size of US$ 489 million by 2031 with a CAGR of 21.0% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 77
USD 4250.00 (Single User License)Global Biologic Products in Nerve Repair Market Research Report 2026
The global Biologic Products in Nerve Repair market was valued at US$ 156 million in 2025 and is anticipated to reach US$ 581 million by 2032, at a CAGR of 21.0% from 2026 to 2032.
Published: 2026-04-28
Pages: 114
USD 2900.00 (Single User License)Biologic Products in Nerve Repair- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biologic Products in Nerve Repair was estimated to be worth US$ 156 million in 2025 and is projected to reach US$ 581 million, growing at a CAGR of 21.0% from 2026 to 2032.
Published: 2026-07-15
Pages: 129
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research